Ind-Swift has received renewed approval for its 100% Export Oriented Unit (Global Business Unit (GBU)) situated at Punjab for a period of three years from Medicines & Healthcare Products Regulatory Agency (MHRA), London, United Kingdom. The approval is based on the assessment undertaken by the agency of company’s quality metrics and quality systems.
Ind-Swift is Chandigarh based pharmaceutical company, established in 1986 with a mission of winning global customers through innovative pharmaceutical products.